Actively Recruiting
Streamlined Renal Denervation Procedure Using Symplicity Spyral System for Adults with Uncontrolled Hypertension A Sub-study of SPYRAL AFFIRM
Led by Medtronic Vascular · Updated on 2026-10-16
130
Participants Needed
21
Research Sites
130 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the long-term safety, effects, and durability of the Symplicity Spyral system for renal denervation in adults with uncontrolled hypertension. It compares a streamlined procedure targeting the main and first order branch renal arteries to approaches used in earlier clinical studies that targeted all accessible renal arteries. The study focuses on whether this method shortens procedure time while effectively lowering blood pressure. Participants undergo renal angiography followed by the renal denervation procedure using the Symplicity Spyral multi-electrode system. The study is conducted under the broader SPYRAL AFFIRM protocol in the EU and APAC regions. This streamlined approach is studied to determine if it maintains effectiveness with a shorter procedure time compared to previous methods. During the study, participants will have their blood pressure regularly monitored through office measurements, home blood pressure readings, and 24-hour ambulatory monitoring over up to 36 months. Researchers will assess changes in blood pressure, medication use, kidney function, and health status scores. Safety events and procedure time are also closely tracked to evaluate the treatments impact over the long term.
CONDITIONS
Brief Title
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Research Team
A
Adela Martinez Sanchez
C
Carly Loudoun
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here